Treatment of advanced colorectal cancer with 5-fluorouracil and interferon-α: An overview of clinical trials

This publication has 19 references indexed in Scilit:

• Double modulation of 5-fluorouracil in advanced colorectal cancer with low-dose interferon-α2b and folinic acid. The “GISCAD” experience
  European Journal Of Cancer, 1994
• 5-Fluorouracil Monotherapy versus Folinic Acid and 5-Fluorouracil in Advanced Colorectal Cancer: Results of a Randomized Trial
  Oncology Research and Treatment, 1993
• Prognostic factors in patients with metastatic colorectal cancer receiving 5-fluorouracil and folinic acid
  European Journal Of Cancer, 1992
• Decreased Catabolism of Fluorouracil in Peripheral Blood Mononuclear Cells During Combination Therapy With Fluorouracil, Leucovorin, and Interferon -2a
  JNCI Journal of the National Cancer Institute, 1992
• Stimulation of 5-fluorouracil metabolic activation by interferon-α in human colon carcinoma cells
  Biochemical and Biophysical Research Communications, 1992
• Treatment of Advanced Colorectal Cancer with Recombinant Interferon Alpha and Fluorouracil: Activity in Liver Metastasis
  Cancer Investigation, 1992
• Interferon potentiates cytotoxic effects of 5-fluorouracil on cell proliferation of established human cell lines originating from neoplastic tissues
  Cancer Letters, 1983
• The enhancement of 5-fluorouracil antimetabolic activity by leucovorin, menadione and α-tocopherol
  European Journal of Cancer and Clinical Oncology, 1982
• Enhanced 5-Fluorouracil Nucleotide Formation After Methotrexate Administration: Explanation for Drug Synergism
  Science, 1979
• Interferon and Spontaneous Cytotoxicity in Man
  Acta Medica Scandinavica, 1978